The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...
The FDA just approved a first-of-its kind medication, meaning there is now a “complete, non-invasive option” for people with this common type of visual impairment.
Morning Overview on MSN
FDA clears 1st dual-action eye drop to fight age-related vision loss
Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...
The Chosun Ilbo on MSN
Presbyopia eye drops YUVEZZI nears South Korean release
The market for presbyopia eye drops, which can sharpen vision with just one drop, is expected to officially open in South ...
Credit: Alcon. Access initiatives including a First Fill Free trial program and an ongoing copay support will be available for eligible patients. The active ingredient in Tryptyr is acoltremon, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results